Aemetis (NASDAQ:AMTX) Stock Rating Upgraded by StockNews.com

Aemetis (NASDAQ:AMTX) was upgraded by analysts at StockNews.com to a “sell” rating in a report released on Friday.

Separately, HC Wainwright restated a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Price Performance

Aemetis stock opened at $2.97 on Friday. The firm has a market cap of $147.71 million, a PE ratio of -1.31 and a beta of 1.47. The stock’s fifty day moving average price is $3.27 and its two-hundred day moving average price is $2.98. Aemetis has a one year low of $2.10 and a one year high of $7.03.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the previous year, the business posted ($0.59) EPS. Sell-side analysts expect that Aemetis will post -2.02 earnings per share for the current fiscal year.

Institutional Trading of Aemetis

Hedge funds and other institutional investors have recently made changes to their positions in the company. FMR LLC lifted its stake in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after buying an additional 9,137 shares during the period. Hutchinson Capital Management CA acquired a new position in shares of Aemetis during the 2nd quarter valued at $70,000. Barclays PLC boosted its stake in Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares in the last quarter. Rhumbline Advisers grew its holdings in Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after purchasing an additional 66,031 shares during the period. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.